Business Description
Cargo Therapeutics Inc
NAICS : 541714
SIC : 8731
ISIN : US14179K1016
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 14.16 | |||||
Equity-to-Asset | 0.89 | |||||
Debt-to-Equity | 0.07 | |||||
Debt-to-EBITDA | -0.19 | |||||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Future 3-5Y EPS without NRI Growth Rate | 35.08 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 48.82 | |||||
9-Day RSI | 43.65 | |||||
14-Day RSI | 42.12 | |||||
6-1 Month Momentum % | 4.24 | |||||
12-1 Month Momentum % | -33.02 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 18.95 | |||||
Quick Ratio | 18.95 | |||||
Cash Ratio | 18.71 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -2.7 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -51.17 | |||||
ROA % | -40.59 | |||||
ROIC % | -361.59 | |||||
ROC (Joel Greenblatt) % | -479.29 | |||||
ROCE % | -43.65 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 1.68 | |||||
Price-to-Tangible-Book | 1.68 | |||||
EV-to-EBIT | -1.95 | |||||
EV-to-Forward-EBIT | -1.67 | |||||
EV-to-EBITDA | -2.04 | |||||
EV-to-FCF | -2.13 | |||||
Price-to-Net-Current-Asset-Value | 1.87 | |||||
Price-to-Net-Cash | 1.9 | |||||
Earnings Yield (Greenblatt) % | -51.28 | |||||
FCF Yield % | -20.98 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CRGX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Cargo Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -3.548 | ||
Beta | 0 | ||
Volatility % | 63.48 | ||
14-Day RSI | 42.12 | ||
14-Day ATR ($) | 1.394456 | ||
20-Day SMA ($) | 16.0065 | ||
12-1 Month Momentum % | -33.02 | ||
52-Week Range ($) | 12.17 - 33.92 | ||
Shares Outstanding (Mil) | 46.03 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Cargo Therapeutics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Cargo Therapeutics Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Cargo Therapeutics Inc Frequently Asked Questions
What is Cargo Therapeutics Inc(CRGX)'s stock price today?
When is next earnings date of Cargo Therapeutics Inc(CRGX)?
Does Cargo Therapeutics Inc(CRGX) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |